Contract Service Directory
Lonza Capsules and Health Ingredients
Company Headquarters
412 Mt. Kemble Ave.
Morristown, NJ 07960
United States
Company Description
Lonza Capsules and Health Ingredients (CHI) is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With an invaluable global production and supply chain footprint, we strive to provide the highest level of quality products and offer regulatory expertise to our 2,000 pharmaceutical customers worldwide.
Contract Service Directory
- 505(b)(2)
- Analytical Laboratory Services
- Animal Health
- Anti-Counterfeiting Technology
- Bioavailability Studies
- Coating & Lamination
- Distribution, Clinical Trials
- Dosage Form Development
- Drug Delivery Systems
- Drug Design
- Drug Development Services
- Encapsulation
- Excipients
- Filling, Capsule
- Formulation Development
- Formulation Services
- Formulation, Controlled Release
- Hot Melt Extrusion
- Manufacturing Equipment and Supplies
- Manufacturing, API
- Manufacturing, Bioequivalence
- Manufacturing, Capsules
- Manufacturing, Clinical Trials Supply
- Manufacturing, Generics
- Manufacturing, Inhalables
- Manufacturing, Liquids
- Manufacturing, Oral Drug Delivery
- Manufacturing, OTC
- Manufacturing, Soft Gels
- Manufacturing, Solid Dosage
- Microdosing
- Micronization
- Packaging, Anti-Counterfeiting
- Packaging, Capsules
- Packaging, Clinical Trial Materials
- Packaging, Clinical Trials
- Particle Characterization
- Particle Size Analysis
- Preformulation
- Supplier, Excipients
Contract Services Directory
Content From Lonza Capsules and Health Ingredients
-
Capsule Delivery Solutions from Lonza Pharma & Biotech
Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is the leader in capsule-based solutions and services, proudly offering Capsugel® products.Sponsored Content Released on 05.20.2019
Related Content
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Cytiva Delivers Modular Biologics Factory to Lonza
Site to become a strategic base in China for Lonza to provide CDMO services throughout Asia Pacific region.Contract Pharma Staff 01.14.21
-
APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
LSNE Expands Fill Finish and Lyophilization Ops
New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.Contract Pharma Staff 01.14.21
-
Clinical Development
Innovate | Integrate | Customize | Accelerate
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
RheinCell Therapeutics Achieves GMP Certification
Marks a milestone for the evolution of the company.Contract Pharma Staff 01.13.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
EVOQ Therapeutics and Amgen Partner
Collaborate on the discovery and development of novel drugs for autoimmune disorders.Contract Pharma Staff 01.13.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.Contract Pharma Staff 01.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Adagene Achieves CAR-T Collaboration Milestone
Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.Contract Pharma Staff 01.12.21
-
Breaking News | Formulation Development | Industry News
Hovione Launches ASD-HIPROS
Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.Contract Pharma Staff 01.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Parenterals
Irisys Receives NIH Contract for the Formulation of Drinabant
Seeks to develop a drug for treatment of acute cannabinoid overdose.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.Contract Pharma Staff 01.11.21
-
-
Clinical Trials | CRO News
Caprion-HistoGeneX Acquires Clinical Logistics
Expands its support of clinical trials specimen logistics.Contract Pharma Staff 01.08.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing
Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.Contract Pharma Staff 01.08.21
-
Promotions & Moves
Ionis Appoints Clinical Development EVP
Eugene Schneider will oversee clinical development of novel antisense medicines across all of Ionis' therapeutic franchises.Contract Pharma Staff 01.08.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Biogen Licenses CEVEC AAV Mfg. Technology
Biogen gains rights to ELEVECTA Technology for manufacturing of gene therapy products.Contract Pharma Staff 01.08.21
-
Aseptic Processing | Breaking News | Collaborations & Alliances | Parenterals
Catalent Divests Blow-Fill-Seal Sterile CDMO Business
SK Capital makes the acquisition; new independent company to be formed.Contract Pharma Staff 01.07.21
-
APIs | Breaking News | cGMP Manufacture | Facilities | Industry News
AmbioPharm Opens New Shanghai Campus
Adds European executive team members working out of new Zurich office.Contract Pharma Staff 01.07.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Oligonucleotides
Innovate | Integrate | Customize | Accelerate
-
-
Breaking News
Bioclinica Acquires Saliency
Integrates the company's advanced AI technology into its Imaging Platform.Contract Pharma Staff 01.06.21
-
-
Breaking News | Clinical Trials | Promotions & Moves
Parexel Appoints Chief Patient Officer
Demonstrates the company’s commitment to elevating the patient perspective.Contract Pharma Staff 01.06.21
-
Food Studies
...
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Genezen Laboratories Receives Growth Equity Investment
Will fund the completion of the company’s lentiviral vector production facility.Contract Pharma Staff 01.05.21
-
Breaking News | Collaborations & Alliances | Industry News
Angelini Pharma Acquires Arvelle Therapeutics for $960M
Angelini to become a leader in CNS and mental health disorder treatments; opening direct affiliates in France, UK, Nordics and Switzerland by 2022.Contract Pharma Staff 01.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Will manufacture second-generation COVID-19 vaccine, AKS-452.Contract Pharma Staff 01.05.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm to Invest $40M in New Facility
State-of-the-art viral vector and advanced therapy process development and manufacturing facility will be located in Boston area.Contract Pharma Staff 01.05.21
-
Drug Development | Industry News | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21
-
-
Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
Charles River Labs Acquires Distributed Bio
Establishes integrated, large molecule discovery platform.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AGC Biologics Manufactures Orchard Therapeutics' Libmeldy
European Commission approves one-time therapy for early-onset Metachromatic Leukodystrophy, manufactured at AGC's Milan facility.Contract Pharma Staff 01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
Partnership adds Asian manufacturing resource to INOVIO's global manufacturing consortium for INO-4800.Contract Pharma Staff 01.04.21
-
Clinical Trials | Drug Development
Impact of Decentralized Trials in Oncology Drug Development
Join us on 2/9 as clinical, regulatory and real-world evidence experts discuss the impact of decentralized trials on the evolution of drug dev in oncology.01.04.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Lonza Expands Conjugation Facility in Visp
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.Contract Pharma Staff 12.21.20
-
Breaking News | Industry News | Trials & Filings
Moderna Wins FDA Authorization for COVID-19 Vax
The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1%.Contract Pharma Staff 12.21.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioNTech, Shanghai Fosun Pharma to Supply COVID-19 Vax to China
Sign an agreement to provide 100 million doses of their BNT162 mRNA-based vaccine candidate in 2021.Contract Pharma Staff 12.18.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.Contract Pharma Staff 12.17.20
-
APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Aurinia and Lonza Expand Manufacturing Partnership
Form agreement for voclosporin manufacturing capacity.Contract Pharma Staff 12.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Information Technology | QA/QC
CDMO Cognate BioServices Teams Up with L7 Informatics
To implement L7|ESP for integrated manufacturing and lab operations.Contract Pharma Staff 12.16.20
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
CHA Biotech Launches Global CDMO Biz
Matica Biotechnology to construct GMP facility for viral vector production in Texas.Contract Pharma Staff 12.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
INOVIO to Develop dMAb COVID Treatments under DARPA Grant
$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.Contract Pharma Staff 12.15.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly to Acquire Prevail Therapeutics in $1B Deal
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.Contract Pharma Staff 12.15.20
-
![[VIRTUAL LAUNCH] Redefining Virus Manufacturing with NevoLine™ Upstream](https://dev.rodpub.com/images/224/959_thumb.jpg)
[VIRTUAL LAUNCH] Redefining Virus Manufacturing with NevoLine™ Upstream
Directly from its development site in Belgium, Univercells Technologies is inviting you to join the virtual product launch of this breakthrough technology.12.14.20
-
-
-
-
-
Got Floor Space? – Increase Workspace Efficiency
By JULIE MENO, Strategic Initiatives Manager, FEDERAL EQUIPMENT COMPANY
-
Breaking News | Industry News
AstraZeneca to Acquire Alexion in $39B Deal
Expands scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline, and top seller Soliris.Contract Pharma Staff 12.14.20
-
Clinical Trials | Drug Development | Information Technology
Advancing Digital Endpoints in Clinical Trials
An end-to-end approach to managing wearable devices through clinical development.Kristin Brooks, Contract Pharma 12.14.20
-
Breaking News | Industry News
CPI Scales Up Manufacturing of Pyocin S5
A promising treatment for lung infection in cystic fibrosis patients developed by the University of Glasgow.Contract Pharma Staff 12.14.20
-
Clinical Trials | Information Technology
Life Sciences Strive for Greater Agility
Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.Ronan Brown, SVP of Integrated Technology & Compliance, and Joe Rymsza, VP, Global PV & Regulatory Technology Solutions, IQVIA 12.14.20
-
Breaking News | Cytotoxics and High Potency Manufacturing | Drug Delivery | Facilities | Industry News
Inhalation CDMO Vectura Expands HPAPI Capabilities
New facility will increase containment operations at Chippenham, UK site.Contract Pharma Staff 12.14.20
-
Drug Development
Navigating Uncertainty: Considerations for Life Sciences 2021
With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
Ascentage Selects PharmaBlock as Preferred Provider
PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.Contract Pharma Staff 12.11.20
-
Breaking News | cGMP Manufacture | Industry News
Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies
Completion of dedicated cGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS product candidates.Contract Pharma Staff 12.10.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Orgenesis, Cure Therapeutics Form JV
Aims to advance point-of-care development and commercialization of cell and gene therapies.Contract Pharma Staff 12.10.20
-
Breaking News | Drug Development | Promotions & Moves
Catalent Appoints Minakuchi Facility GM
Nakaya “Nick” Matsumaru joins the company from SymBio Pharmaceuticals.Contract Pharma Staff 12.10.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Boehringer to Acquire NBE-Therapeutics in €1.2B Transaction
Gains iADC platform and potential best-in-class antibody-drug conjugate (ADC) therapies for the treatment of solid tumors.Contract Pharma Staff 12.10.20
-
Breaking News | Industry News | Trials & Filings
Health Canada Authorizes Pfizer, BioNTech COVID-19 Vax
Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses and up to 76 million doses of the vaccine through 2021.Contract Pharma Staff 12.10.20
-
Breaking News | Cold Chain Management | Facilities | Industry News | Logistics | Supply Chain
Logistics4Pharma Facility Passes Inspection
German logistics firm completes validation of GDP cold chain storage and transportation at Frankfurt facility.Contract Pharma Staff 12.09.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Health Canada Green Lights COVID-19 Vax
Canadian regulator authorizes supply and emergency use of Pfizer and BioNTech’s COVID-19 mRNA vaccine.Contract Pharma Staff 12.09.20
-
APIs | Breaking News | Clinical Trial Materials | Facilities | Industry News
Recipharm Expands API Manufacturing Capabilities
Invests $2.5 million in clinical GMP capacity for APIs at Israel facility.Contract Pharma Staff 12.09.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
atbtherapeutics, iBio CDMO Enter Manufacturing Agreement
Will work together for the industrialization of the GMP manufacturing process of atbtherapeutics’ atbodies.Contract Pharma Staff 12.09.20
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma
Technology transfer to Qilu anticipated to be completed in mid-2021.Contract Pharma Staff 12.09.20
-
Breaking News | CRO News | Industry News | R&D
LINK Medical Acquires IRW Consulting AB
Strengthens its position in the Nordics while improving its offerings and capabilities.Contract Pharma Staff 12.09.20
-
Breaking News | Promotions & Moves
Natoli Engineering Appoints West Coast Service Tech
Gerardo Zuniga brings 20 plus years of experience leveraging problem-solving techniques to implement corrective and preventative actions.Contract Pharma Staff 12.08.20
-
APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Piramal Invests $32M to Expand Michigan Facility
Includes additional capacity in Potent and Non-Potent API development and manufacturing.Contract Pharma Staff 12.08.20
-
Breaking News | cGMP Manufacture | Industry News | QA/QC | Validation
UK’s VMIC to Implement Lonza’s MODA-EM
To digitize its Microbiology Quality Control operations.Contract Pharma Staff 12.08.20
-
Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Catalent Invests $10M in Isolator Capabilities to Expand Micronization
Will allow flexible jet milling ops to be carried out at sites in Malvern, PA and Dartford, U.K. under high containment.Contract Pharma Staff 12.04.20
-
Clinical Trials
Adapting to Pandemic Restrictions While Launching a Phase 3 Trial
The pandemic has forced companies to reimagine how trials can be conducted, and to think differently about the future of all their clinical trials.
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Keneka Eurogentec Joins Inovio’s Global Mfg. Consortium
Agrees to manufacture Innovio’s Covid-19 vaccine candidate INO-4800.Contract Pharma Staff 12.03.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact
Will advance a new generation of antibody-drug conjugates towards clinical evaluation.Contract Pharma Staff 12.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Batavia Biosciences and KU Leuven Join Forces
Will accelerate the development of a highly promising Covid-19 vaccine candidate.Contract Pharma Staff 12.03.20
-
Breaking News | Drug Development
ViGeneron and WuXi Advanced Therapies Enter Partnership
Will accelerate production for the clinical development of VG901, a next-generation ophthalmic gene therapy program.Contract Pharma Staff 12.02.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lonza Enters Long-term Bioconjugation Collaboration
Will construct two new customer-dedicated conjugation suites for the commercialization of antibody-drug conjugates at its Visp site.Contract Pharma Staff 12.02.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Trials & Filings
Pfizer, BioNTech Win First Authorization for COVID-19 Vax
MHRA authorizes supply of BNT162b2 vaccine for emergency supply; companies are ready to deliver the first doses to the U.K. immediately.Contract Pharma Staff 12.02.20
-
Breaking News | Drug Development | Promotions & Moves
NeuBase Therapeutics Appoints Chief Scientific Officer
Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.Contract Pharma Staff 12.02.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
KBI Biopharma Expands U.S. Ops
Invests $150 million in commercial biologics manufacturing facility in RTP, NC.Contract Pharma Staff 12.02.20
-
Pfizer, BioNTech Submit CMA for Covid-19 Vax to EMA
Approval could potentially enable the use of BNT162b2 in Europe before the end of 2020.Contract Pharma Staff 12.01.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
CDMO Stelis Continues Expansion
Starts next phase of investment into its biologics manufacturing facility.Contract Pharma Staff 12.01.20
-
Breaking News | Clinical Trials | Industry News
SGS Initiates U.S. COVID-19 Clinical Trials
Phase 2/3 trial will examine the safety, tolerability, and efficacy of Sarconeos (BIO101) to treat COVID-19 related respiratory failure.Contract Pharma Staff 11.30.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
Lonza Expands Development, Mfg. Capabilities at Bend Site
Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.Contract Pharma Staff 11.30.20
-
-
APIs | Breaking News | Facilities | Industry News
CordenPharma Colorado Increases US Peptide Manufacturing Capacity
Long-term expansion initiative approved to further increase flexibility, efficiency and ultimately, cost-effective production.Contract Pharma Staff 11.25.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
Manufacturing at Wacker’s biotech site in Amsterdam is scheduled to start in the first half of 2021.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Supply Chain
Lonza and Be The Match BioTherapies Enter CGT Partnership
Will expand Vein-to-Vein Cell and Gene Therapy Supply Chain Network.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | Facilities | Industry News
Samsung Biologics Breaks Ground on 'Super Plant'
When completed, the CDMO says it will be the world's largest bio-manufacturing facility.Contract Pharma Staff 11.24.20
-
Drug Delivery | Drug Development
Inhaled Drug Delivery Technology Trends
The success of new inhaled medicines relies on the correct combination of formulation and device technology.Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20
-
Breaking News | Clinical Trials | Industry News
Merck Acquires OncoImmune for $425M
Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19.Contract Pharma Staff 11.24.20
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Fill/Finish | Industry News | Injectables | Lyophilization | Parenterals
Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
Construction currently underway; expected to be completed in 2021.Contract Pharma Staff 11.24.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's COVID-19 Antibody Cocktail Gets EUA
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.Contract Pharma Staff 11.23.20
-
Breaking News | Promotions & Moves
Summit Therapeutics Appoints Chief Operating Officer
Dr. Mahkam Zanganeh previously founded and led Maky Zanganeh and Associates consulting services firm.Contract Pharma Staff 11.23.20
-
Breaking News | Collaborations & Alliances | Drug Development
Amgen Ends Cardio Alliance with Cytokinetics
Will transition the development and commercialization rights for omecamtiv mecarbil to Cytokinetics and Servier.Contract Pharma Staff 11.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
Initiation of ASPEN-COVID-19 Phase 2b clinical trial anticipated in December with trial data anticipated 2Q21.Contract Pharma Staff 11.23.20
-
Breaking News | Industry News | Promotions & Moves
Frontida BioPharma Appoints EVP Technology
Dr. Praful Agrawala brings years of pharmaceutical product development leadership experience to the company.Contract Pharma Staff 11.20.20
-
Bio News | Breaking News | cGMP Manufacture | Facilities | Fill/Finish | Industry News
August Bioservices Expands Operations in Nashville
Plans to invest $64.7 million and create 180 jobs over the next five years.Contract Pharma Staff 11.20.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.Contract Pharma Staff 11.20.20
-
Promotions & Moves
Catalent Appoints Open Innovation, Biologics, Cell and Gene Therapy VP
Behzad Mahdavi brings more than 20 years of experience in developing and implementing growth strategies in the biopharmaceutical industries.Contract Pharma Staff 11.19.20
-
Collaborations & Alliances | Drug Development
Cue Biopharma, Merck Extend Biologics Research Alliance
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.Contract Pharma Staff 11.19.20
-
Biologics, Proteins, Vaccines | Industry News
Avantor Opens New Biorepository Facility in Europe
Supports growing demand for scientific research and clinical trial sample storage.Contract Pharma Staff 11.19.20
-
Breaking News | CRO News | Facilities | Industry News
SGS Plans to Move Its Clinical Pharmacology Unit
Increases its capacity to conduct Human Challenge studies.Contract Pharma Staff 11.18.20
-
cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News
Lonza Expands HPAPI Capabilities
Invests more than $15 million to expand and upgrade the Tampa, FL site.Contract Pharma Staff 11.18.20
-
Breaking News | Facilities | Industry News
CordenPharma Expands Peptide Development Capacity
Increases CoE for peptide development capacity to support European domestic growth.Contract Pharma Staff 11.18.20
-
Breaking News | Facilities | Industry News
Comar Breaks Ground in Vineland, NJ
New 159,000 square-foot site will house injection molding machines, proprietary automation, and packaging equipment.Contract Pharma Staff 11.18.20
-
Breaking News | Industry News | Information Technology | Promotions & Moves
Sharp Implements Cloud-Based QMS
Strengthens quality leadership with new appointments.Contract Pharma Staff 11.18.20
-
Bio News | Breaking News | Industry News
Bionova Scientific Secures First Client Commitment
Its new biologics manufacturing facility is still months from completion.Contract Pharma Staff 11.18.20
-
APIs | Breaking News | Industry News
Almac Gets Grant From COVID-19 Therapeutics Accelerator
Will work to enable efficient manufacturing of remdesivir in Response to COVID-19.Contract Pharma Staff 11.18.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Syntegon Opens New OSD Customer Center
Six times more cleanroom capacity for customer projects in Waiblingen, Germany.Contract Pharma Staff 11.18.20
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
A Potential “Marriage”
Initiator companies and generics/CMOs working together.Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
-
Injectables Firms Expand Capacity
CDMOs see steriles demand grow.S. Harachand, Contributing Editor 11.17.20
-
Clinical Trials | Information Technology | R&D
Decentralized Trials Fuel AI Revolution in Clinical Research
The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20
-
Biologics, Proteins, Vaccines | Inspections | Supply Chain
Inspecting the Unexpected
Preparing quality control processes for COVID-19 vaccine candidates.Dr. Andrea Sardella and Raffaele Pace, Stevanato Group 11.17.20
-
Scale-up/Technology Transfer
Ensuring Quality During the Transfer and Scale Up of Rx Drugs
Defining the key parameters and considerations for a successful technology transfer.Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20
-
Breaking News
Syneos Health Appoints Chief Information & Digital Officer
Larry A. Pickett brings 30 years of relevant experience.Contract Pharma Staff 11.17.20
-
Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities
Opportunities in Synthetic Biology
Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.Contract Pharma Staff
-
Collaborations & Alliances | Drug Development
XOMA Earns $2M Takeda Milestone
Mezagitamab advances into Phase 2 development in generalized myasthenia gravis.Contract Pharma Staff 11.17.20
-
Capsules | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
Double-blinding and removing bias with over-encapsulation
While there are many blinding options available, over-encapsulation remains the most popular method adopted by sponsors to meet regulatory demands.
-
G2GBio Deploys Micropore’s Membrane Technology
Plans to manufacture sustained release pharmaceutical products.Contract Pharma Staff 11.16.20
-
Breaking News | Industry News | Promotions & Moves
Pii Appoints Business Development Director
Brian Sasaki brings 20 years of experience to the role.Contract Pharma Staff 11.16.20
-
Breaking News | Collaborations & Alliances | Industry News
Lead Pharma and Roche Enter Collaboration & License Agreement
Will develop oral small molecules to treat immune mediated diseases.Contract Pharma Staff 11.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Vibalogics Establishes U.S. Presence
Will open virotherapy facility in Boston and plans to invest $150 million.Contract Pharma Staff 11.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Cellular Dynamics, Lonza Enter Cell Therapy Pact
Agree to expand availability and use of induced pluripotent stem cell technology.Contract Pharma Staff 11.16.20
-
Clinical Trials | Information Technology
AI and Advanced Analytics
Equipped with the right tools, CROs are better positioned to develop optimal protocols, rapidly identify patients to enroll, and preempt study issues.Paul Oliver, Medidata 11.13.20
-
Clinical Trials | Information Technology
eCOA: Addressing Barriers to Faster Deployment in Clinical Trials
Clinical Outcome Assessments are an increasingly important tool in clinical research.Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata 11.13.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Swissmedic Begins Rolling Review of Moderna’s mRNA COVID-19 Vax
Moderna completed enrollment of its Phase 3 COVE study of mRNA-1273 on October 22.Contract Pharma Staff 11.13.20
-
Breaking News | Collaborations & Alliances | Industry News
AzurRx BioPharma Partners with Asymchem
Will develop and produce MS1819 for the treatment of exocrine pancreatic insufficiency.Contract Pharma Staff 11.12.20
-
Bio News | Breaking News | Facilities | Industry News
Stelis BioSource Continues Facility Investment
Will install two 2,000L single-use bioreactor trains in its mammalian CGMP facility.Contract Pharma Staff 11.12.20
-
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
CDMOs: Keeping up with Science & Technology
Enhancing the development of increasingly advanced and complex drug candidates is needed to drive growth in the industry.Kristin Brooks, Contract Pharma 11.12.20
-
Lyophilization
LSNE Contract Manufacturing – The Recognized Leader in Lyophilization and Sterile Manufacturing
A history of execution. A reputation for excellence.
-
Biologics, Proteins, Vaccines | Breaking News | Promotions & Moves
Novavax Makes Leadership Changes
Appoints Gregory F. Covino as executive vice president and chief financial officer.Contract Pharma Staff 11.11.20
-
Breaking News | Industry News
Pfizer, BioNTech to Supply 200M Doses of BNT162b2 to EU
Deliveries are anticipated to start by the end of 2020, subject to clinical success and regulatory authorization.Contract Pharma Staff 11.11.20
-
Breaking News | Industry News
TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity
Strategic partnership will leverage technical capabilities at ElevateBio for the production of TC-210 to support Phase II clinical trial.Contract Pharma Staff 11.11.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Altimmune Adds Lonza as Mfg. Partner for Supply of AdCOVID
Single-dose intranasal vaccine for COVID-19 designed to generate a broad immune response with nasal mucosal immunity to prevent infection and transmission.Contract Pharma Staff 11.11.20
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Parenterals
Ypsomed Collaborates with Schott and Lonza
Aims to deliver a comprehensive solution for wearable patch injectors.Contract Pharma Staff 11.10.20
-
Breaking News | CRO News | Industry News | Information Technology
RhoFED Wins BARDA Contract
Will serve to standardize data collection, management, and analysis across BARDA-supported network studies.Contract Pharma Staff 11.10.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
AC Immune and WuXi Biologics Expand Strategic Partnership
Plan to accelerate AC Immune’s TDP-43 antibody into clinical development.Contract Pharma Staff 11.10.20
-
Breaking News | CRO News | Drug Discovery | Industry News
MercachemSyncom Acquires Admescope
Significantly expands its capabilities for in vitro and in vivo studies.Contract Pharma Staff 11.10.20
-
Breaking News | Facilities | Industry News | Logistics | Packaging & Tracking | Supply Chain
Pharmaceutical Logistics Company Expands in San Antonio
WDSrx expands into San Antonio providing pharmaceutical warehousing and logistics from 1310 Cornerway Boulevard.Contract Pharma Staff 11.10.20
-
Bioassay Development | Breaking News | Industry News
GenScript Gets EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit
cPass SARS-CoV-2 Neutralization Antibody kit is the only EUA authorized virus-free testing assay that detects neutralizing antibodies within an hour.Contract Pharma Staff 11.10.20
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Altimmune Adds Lonza as a Manufacturing Partner
For supply of AdCOVID, its single-dose intranasal vaccine candidate for COVID-19.Contract Pharma Staff 11.10.20
-
Breaking News | Drug Development | Promotions & Moves
Inozyme Pharma Appoints SVP, Regulatory Affairs
Dr. Kevin B. Johnson brings over 25 years of experience to the role.Contract Pharma Staff 11.09.20
-
Breaking News | Collaborations & Alliances | Drug Development
PhoreMost, Oxford Biomedica Enter CAR-T Collaboration
Aims to develop next-gen CAR-T cell therapies leveraging SITESEEKER and LentiVector platforms.Contract Pharma Staff 11.09.20
-
Breaking News | Industry News | Packaging & Tracking
Rondo-Pak Expands Capacity at Primary Facilities
Newly incorporated equipment includes a Koenig & Bauer Iberica Optima 106 Die-Cutter and a Bobst Expertfold 110 Folder-Gluer.Contract Pharma Staff 11.09.20
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
OM Pharma and AstraZeneca Sign Collaboration Agreement
Will improve the accessibility of Broncho-Vaxom and accelerate its growth in the Chinese market.Contract Pharma Staff 11.06.20
-
Aseptic Processing | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Argonaut Manufacturing Services Completes First cGMP Run
New automated aseptic fill/finish line for clinical and commercial use was recently approved by regulators.Contract Pharma Staff 11.06.20
-
Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Fareva Expands Sterile Production Capabilities
Grows footprint with site acquisition in France and Austria.Contract Pharma Staff 11.06.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Novavax to Supply COVID-19 Vaccine Candidate to Australia
Delivery will start as early as the first half of 2021.Contract Pharma Staff 11.05.20
-
Breaking News | Facilities | Industry News
Eurofins CDMO Expands Drug Product Capabilities in Canada
14,500 sq. ft. expansion includes new development labs and GMP manufacturing suites.Contract Pharma Staff 11.05.20
-
Financial Reports
Financial Report: Merck
Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products.Contract Pharma Staff 11.04.20
-
Excipients
Pharmaceutical Excipients Market Poised for Growth
The global pharmaceutical excipients market is estimated to surpass $11,944.6 million by 2027.Contract Pharma Staff 11.03.20
-
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
TFF Expands Engagement with Experic
Agrees to install a TFF processing line and its associated capabilities at Experic’s cGMP facility in NJ.Contract Pharma Staff 11.03.20
-
-
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Sensorion and Novasep Sign Agreement
Covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs.Contract Pharma Staff 11.03.20
-
-
-
Working with Clinical Research Sites: Strategic Planning and Operations for Sponsors and CROs
...11.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi to Acquire Kiadis for $359M
Adds next-gen natural killer cell platform and pipeline of cell-based cancer immune-therapeutics and infectious disease therapies.Contract Pharma Staff 11.03.20
-
Breaking News | CRO News | Facilities | Industry News | R&D
Reach Separations Expands Nottingham Premises
Responds to increased demand for its chiral purification services.Contract Pharma Staff 11.03.20
-
Bio News | Breaking News | cGMP Manufacture | Industry News
eTheRNA Extends mRNA Production Services
Adds high throughput research grade mRNA to its GMP capabilities.Contract Pharma Staff 11.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Novartis Expands Kymriah Manufacturing Footprint
Gets green light for commercial CAR-T cell therapy manufacturing site in Asia.Contract Pharma Staff 11.03.20
-
cGMP Manufacture | Fill/Finish | Scale-up/Technology Transfer
Ramping Up COVID-19 Vaccine Fill and Finish Capacity
As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.Kristin Brooks, Contract Pharma 11.03.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Fusion Pharma, AstraZeneca Enter Radiopharmaceuticals Alliance
Leverages Fusion's Targeted Alpha Therapies platform and radiopharmaceuticals expertise and AstraZeneca's portfolio of antibodies and cancer therapies.Contract Pharma Staff 11.02.20
-
Breaking News | Industry News
Samsung Biologics, Checkpoint Therapeutics Expand Cosibelimab Mfg. Pact
Samsung Biologics will provide additional commercial-scale drug substance manufacturing.Contract Pharma Staff 11.02.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Minaris Invests $64.5M to Expand Cell and Gene Mfg. Facilities
New buildings near Munich, Germany and Yokohama, Japan will more than double capacity for commercial manufacturing of regenerative medicines.Contract Pharma Staff 11.02.20
-
Breaking News | Promotions & Moves
Lonza Appoints CEO
Pierre-Alain brings more than 20 years of experience in biopharmaceuticals.Contract Pharma Staff 11.02.20
-
Breaking News | Industry News | Promotions & Moves
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Lonza to Manufacture AstraZeneca's COVID-19 Long-Acting Antibody Combination
cGMP manufacturing of the two long-acting antibodies to begin in H1 2021 at Lonza's Portsmouth, NH (USA) site.Contract Pharma Staff 10.30.20
-
Breaking News
Syneos Health Agrees to Acquire Synteract
Enhances Syneos Health’s position across the fast-growing small to mid-sized category.Contract Pharma Staff 10.29.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
AB2 Bio and WuXi Biologics Enter Collaboration
Set-up and accelerate commercial-scale manufacturing of Tadekinig alfa.Contract Pharma Staff 10.29.20
-
Financial Reports
Financial Report: PPD
Clinical Development Services revenue up 19% to $1.0 billion in the quarter.Contract Pharma Staff 10.29.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility
Expands cell therapy capabilities and advanced clinical and commercial supply, and creates an integrated European CoE.Contract Pharma Staff 10.29.20
-
Breaking News | Clinical Trials | CRO News
BARDA Reselects ICON as Preferred Partner
Continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies NetworkContract Pharma Staff 10.29.20
-
Breaking News | Financial Reports
Financial Report: Gilead
Veklury (remdesivir) revenues were $873 million in the third quarter.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News
MilliporeSigma Awards Grant to Combined Therapeutics
Supports its nucleic acid platform that targets liver cancer with virotherapy.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
SB3000 Partners with Evaxion
Provides rapid scale up for commercial production of coronavirus vaccines.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Bayer to Pay up to $4B for Gene Therapy Firm AskBio
Purchase includes an established CDMO, lays the foundation for future partnerships in the area of AAV therapies.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News | Promotions & Moves
Valicare Expands Service Portfolio
Recruits Dr. Christin Erbach as senior GMP consultant.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Breaking News | Industry News | Promotions & Moves
DCAT Elects New President
Sean Diver will serve a one-year term, ending October 31, 2021.Contract Pharma Staff 10.28.20
-
Breaking News | Fill/Finish | Parenterals
TurboFil Introduces Syringe Filling & Assembly System
New module is automated and designed for simplified production for a wide range of syringe formats.Contract Pharma Staff 10.27.20
-
Breaking News | Clinical Trials
Thermo Fisher Expands Direct-to-Patient Service
Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.Contract Pharma Staff 10.27.20
-
Breaking News | Collaborations & Alliances | Drug Development
BioInvent, CASI Pharmaceuticals Enter Antibody Alliance
Collaboration accelerates and expands BioInvent's global development plans for BI-1206 in liquid and solid tumors.Contract Pharma Staff 10.27.20
-
Breaking News | Industry News
Stevanato, Catalent Partner to Expedite Equipment Installation
Stevanato’s high-speed visual inspection machines will support biologic and vaccine programs at Catalent manufacturing sites in U.S. and Italy.Contract Pharma Staff 10.27.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
REGENXBIO Achieves $80M Novartis Milestone
Zolgensma, which leverages REGENXBIO's NAV AAV9 vector, reaches $1 billion in sales.Contract Pharma Staff 10.27.20
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
Construction Starts on the Medicines Manufacturing Innovation Center
Will offer next-gen solutions in small molecule and pharmaceutical manufacturing.Contract Pharma Staff 10.26.20
-
The Future of Pharmaceutical Manufacturing: Multi-Product Facility and Equipment Design
Join us for a FREE webinar on November 12 at 11:00 AM EST.10.26.20
-
Breaking News | Collaborations & Alliances
Elsevier, Novartis Collaborate on Risk Assessment Prediction Tool
To develop a safety margin risk assessment prediction tool, largely using PharmaPendium data.Contract Pharma Staff 10.22.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Kamada Signs Supply Agreement with Israeli Health Authorities
Will provide investigational Covid-19 plasma-derived Immunoglobulin.Contract Pharma Staff 10.22.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment
To develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral being studied to treat COVID-19.Contract Pharma Staff 10.22.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
Catalent, BrainStorm Enter ALS Drug Manufacturing Pact
Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.Contract Pharma Staff 10.22.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.10.22.20
-
Breaking News | cGMP Manufacture | Industry News
Lonza Expands Capsule Mfg. Capacity
$93 million investment to expand production capacity of capsules in CHI's Capsugel portfolio by 30 billion capsules annually, or 15%.10.22.20
-
Breaking News | Industry News | Promotions & Moves
Metrics Contract Services Expands Business Development Team
Names Lettie Kirk as business development executive.Contract Pharma Staff 10.21.20
-
Facilities
Vetter Moves Into New HQ
€50 million investment integrates the latest construction and environmental standards.Contract Pharma Staff 10.21.20
-
Aseptic Processing | Breaking News | Collaborations & Alliances | Facilities | Fill/Finish | Industry News | Parenterals
CDMO QCL Expands Fill Finish Capabilities
Partners with AST on flexible, isolated fill finish equipment for new facility expansion.Contract Pharma Staff 10.21.20
-
Vetter continues its long-term investment strategy to sustain future growth
Existing buildings are repurposed as others continue to be built and recently housed
-
Biologics, Proteins, Vaccines
India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines
CMOs expand and ‘repurpose’ capacities.S Harachand, Contributing Editor 10.20.20
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Kristin Brooks, Contract Pharma 10.20.20
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Breaking News | Clinical Trials | Collaborations & Alliances
Cytocom and Cleveland Biolabs Merge
Combine their businesses in an all-stock transaction.Contract Pharma Staff 10.20.20
-
Breaking News | Trials & Filings
Valneva’s Chikungunya Vax Granted PRIME Designation
Becomes the first company worldwide to advance a chikungunya vaccine candidate into Phase III.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Breaking News | Clinical Trials
Mereo Makes Leadership Changes
Appoints CFO and SVP, regulatory affairs.Contract Pharma Staff 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.10.20.20
-
Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
CordenPharma Colorado Completes Highly Potent API Lab Expansion
Capable of handling highly potent compounds with an OEL as low as 1ng/m3.Contract Pharma Staff 10.19.20
-
Bio News | Breaking News | Facilities | Industry News | Parenterals
INCOG BioPharma Launches Central Indiana Ops
New CDMO is investing roughly $60 million to construct and equip a 60,000-square-foot facility in Fishers.Contract Pharma Staff 10.19.20
-
APIs
Emphasizing Sustainability in Contract Manufacturing
Ajinomoto Bio-Pharma Services outlines its commitment to protecting the environment.Contract Pharma Staff
-
Breaking News | Industry News
Arcinova Installs R1000 Robotic Capsule Filler
Increases production to 1000 units per hour, while maintaining the same level of operator labor.Contract Pharma Staff 10.19.20
-
Promotions & Moves
Touchlight Appoints CEO
Karen will work to further expand the company's contract manufacturing business, which delivers GMP materials to third parties developing COVID-19 vaccines.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News
J&J Pauses All Trials Evaluating COVID-19 Vax Candidate
Temporarily pauses further dosing in all COVID-19 vaccine candidate trials to investigate an an unexplained illness.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Pauses ACTIV-3 Clinical Trial in Hospitalized COVID-19 Patients
ACTIV-3 study is evaluating the efficacy of Lilly’s neutralizing antibody in hospitalized COVID-19 patients, the most advanced stage of the disease.Contract Pharma Staff 10.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
The Discovery Labs Appoints President and COO
Taps former Lonza Exec, Jeorg Ahlgrimm.Contract Pharma Staff 10.15.20
-
Breaking News | Capsules | Facilities | Industry News | Solid Dosage/Creams/Ointments
Sirio Europe Invests in Advanced Manufacturing and Green Technologies
Manufacturing facility upgrades at Brandenburg site have increased the CDMO’s production capacity and energy efficiency.Contract Pharma Staff 10.15.20
-
Clinical Trials | Information Technology
The Role of Electronic Monitoring in Maintaining Medication Adherence
Digital solutions offer hope to get patients to take their medications properly.Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20
-
APIs
Understanding the Importance of Crystallization Processes
Crystallization is a crucial aspect of a molecule’s development and can be used to avoid unnecessary cost, risk and development delays.Dr. Craig Callahan, Project Scientist, Cambrex Edinburgh 10.14.20
-
Capsules | Solid Dosage/Creams/Ointments
Capsule Technology Trends
A look at the capsule market with a particular focus on the factors driving increased demand in non-gelatin-based formulations.Julien Lamps, Product Manager, Lonza 10.14.20
-
Aseptic Processing | Fill/Finish
A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility
Overcoming today’s aseptic fill-and-finish process challenges.Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20
-
Breaking News | Collaborations & Alliances | Industry News
RedHill Biopharma Ramps-Up Manufacturing of Opaganib
Collaborates with specialty manufacturers in Europe and Canada.Contract Pharma Staff 10.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B
Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ gene therapy capabilities.Contract Pharma Staff 10.14.20
-
The Pandemic’s Become an Insurmountable Opportunity
Every Cloud has a Silver Lining(?)Emil W. Ciurczak, Contributing Editor 10.14.20
-
Breaking News | Facilities | Industry News
NewAge Industries-AdvantaPure Expands on Recent Purchase of Additional Facility
Will increase critical tubing and molding capacities.Contract Pharma Staff 10.14.20
-
Analytical Services | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing
PPD to Open Multipurpose Clinical Research Lab in Suzhou
Will offer bioanalytical, biomarker and vaccine services for global and China-based biopharma customers.10.14.20
-
Bio News | Breaking News | Facilities | Industry News
CellGenix Expands Facility
Meets the growing demand for GMP raw materials.Contract Pharma Staff 10.13.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Greenwich Lifesciences Completes Manufacturing of GP2
The active ingredient is ready for its planned Phase III clinical trial.Contract Pharma Staff 10.13.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
KindredBio Expands Manufacturing Agreement with Vaxart
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.Contract Pharma Staff 10.13.20
-
Breaking News | Collaborations & Alliances | Industry News
BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1
Partnered with CDMO AMRI for GMP synthesis.Contract Pharma Staff 10.13.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Diosynth to Manufacture Lilly COVID-19 Antibody
Commercial manufacturing of the antibody therapy is expected to commence in April 2021.Contract Pharma Staff 10.13.20
-
Breaking News | Facilities | Industry News | Injectables | Packaging & Tracking
Sharp Invests $10M in Biologics, Injectables Packaging Equipment
Investment includes the installation and validation of two Dividella NeoTopx packaging systems.Contract Pharma Staff 10.13.20
-
Breaking News | Industry News | Inspections
Symbiosis Completes MHRA Regulatory Inspection
Scottish CMO recorded no critical or major observations from the reinspection by the MHRA.Contract Pharma Staff 10.13.20
-
Clinical Trials | Information Technology
Adding Remote Site Access to Sponsor Bids: What to Know as CRO
Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.Ryan Jones, CEO, Florence Healthcare 10.13.20
-
cGMP Manufacture | Drug Development | Promotions & Moves
AGC Biologics Appoints New GM of Milan Site
Luca Alberici will initiate integration efforts resulting from the July 2020 acquisition of MolMed.Contract Pharma Staff 10.12.20
-
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
Abzena Invests $60M Into cGMP Manufacturing Capacity
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.Contract Pharma Staff 10.08.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Mapi Pharma Commissions Facility to Support Supply of COVID-19 Vaccines
Makes available its production, cold-chain and storage capacities for the delivery of vaccines to Israel and the EU.Contract Pharma Staff 10.08.20
-
Breaking News | Collaborations & Alliances | CRO News
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
Will support new medical countermeasure research in the fight against emerging infectious disease.Contract Pharma Staff 10.08.20
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
NextPharma Expands OSD Capacity
Invests €15 million to increase oral solid dosage form manufacturing and packaging capacity at its Goettingen site.Contract Pharma Staff 10.08.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
HHS Funds Development of Needle-free Vax Technology
Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Recipharm, Arcturus Ink LUNAR-COV19 Vax Mfg. Pact
Recipharm to support the manufacture of ARCT-021, Arcturus’ COVID-19 vaccine candidate that is in an ongoing Phase I/II clinical trial.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly Submits EUA Request for COVID-19 Monotherapy
LY-CoV555 and LY-CoV016 combination therapy significantly reduced viral load at day 11, meeting the primary endpoint of the study.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News
Kindred Bio Expands Agreement with Vaxart
Centaur will manufacture Vaxart’s oral vaccine for COVID-19 and other vaccine candidates.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eisai Enters Joint Development Agreement for COVID-19 Therapeutics
Aims to understand the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the aggravation of COVID-19.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News
FDA Issues Guidance on EUA for COVID-19 Vaccines
Provides further information on the EUA process for investigational vaccines.Contract Pharma Staff 10.07.20
-
Breaking News | R&D
Samsung Biologics Adopts Solentim Solutions in R&D Center
Solentim’s instruments will be used in conjunction with Samsung Biologics’ proprietary cell line platform.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Laboratory Testing
CEPI Establishes Global Lab Network to Assess COVID-19 Vax Candidates
Will use the same testing reagents to assess and compare the immunological responses generated by COVID-19 vaccine candidates.Contract Pharma Staff 10.07.20
-
Breaking News | Collaborations & Alliances | Industry News
Irisys Signs Contract with TFF Pharma
Will produce medication to treat lung conditions, including COVID-19.Contract Pharma Staff 10.06.20
-
Breaking News | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Evonik Launches New Oral Drug Delivery Technology
For enteric protection and rapid release in the upper small intestine.Contract Pharma Staff 10.06.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200
Paves the way towards getting OCU200 in the clinic by first half of 2022.Contract Pharma Staff 10.06.20
-
Breaking News | Facilities | Industry News
Sterling Pharma Solutions Opens Material Science Center
Offers specialist solid state chemistry and milling services.Contract Pharma Staff 10.06.20
-
Parenterals
Primary Packaging Considerations Amid COVID-19 Vax Urgency
Fran L. DeGrazio of West discusses why and how vaccine development is different than drug development and the impacts of COVID-19 on vaccine development.Kristin Brooks, Contract Pharma 10.05.20
-
Breaking News | Drug Development | Industry News
BMS to Acquire MyoKardia for $13.1B
Promising portfolio of pipeline candidates strengthens and extends BMS’ cardiovascular franchise.Contract Pharma Staff 10.05.20
-
Reader Showcase
Thermo Fisher Scientific Launches Service for Ultra-Low Temp TSX Freezers
Smart connected services enables active sample and product protection.Contract Pharma Staff 10.05.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cobra Biologics to Manufacture Plasmids for COVID-19 Vax Trial
Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.Contract Pharma Staff 10.05.20
-
Breaking News | Promotions & Moves
3P Expands Management Team
Adds José Luis Bartolomé as operational excellence and continuous improvement director.Contract Pharma Staff 10.02.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
FibroGenesis Collaborates with R4D Biotech
Expands the fight against COVID-19 in Brazil.Contract Pharma Staff 10.02.20
-
Breaking News | Collaborations & Alliances | Facilities | Industry News | Parenterals | Solid Dosage/Creams/Ointments
Siegfried Acquires Two Pharma Manufacturing Sites from Novartis in Spain
Sites are specialized in the manufacturing of ophthalmic steriles as well as oral solid dosage forms and capsules used in inhalation devices.Contract Pharma Staff 10.02.20
-
APIs | Breaking News | Facilities | Industry News
Sterling Pharma Solutions Expands US Operations
Acquires Alcami’s Germantown, WI API facility.Contract Pharma Staff 10.02.20
-
Breaking News | Drug Development
Olema Completes Series C Financing
Raises $85 million to advance clinical development of OP-1250 in breast cancer.Contract Pharma Staff 10.01.20
-
Breaking News | Promotions & Moves
Bioclinica Establishes Medical and Scientific Affairs Organization
Expands Michael O’Neal’s role as chief medical officer.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
Catalent Launches OneXpress Solution
Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.Contract Pharma Staff 10.01.20
-
APIs | Breaking News | Industry News
NCK A/S Receives CoA for Berubicin API
CNS has a contract with NCK A/S for the large-scale production of Berubicin, its lead drug candidate for the treatment of glioma brain tumors.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Industry News | Parenterals | QA/QC
Lonza Expands QC Testing Portfolio
Launches PyroCell MAT System for in vitro Pyrogen testing to help ensure safety of parenteral pharmaceuticals during development, manufacture and release.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
CRB Completes Large-Scale Mfg. Facility for GRAM
GRAM's newest facility was designed to increase its large-scale fill and finish capacity for COVID-19 vaccines and therapeutics.Contract Pharma Staff 10.01.20
-
November 2020: Auction of Packaging Equipment of Vaccines and Injectable Products from Pfizer Havant
United Kingdom
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development
Boehringer, Mirati Therapeutics Enter Clinical Collaboration
To evaluate the combination of BI 1701963, a SOS1::pan-KRAS inhibitor, and MRTX849, a KRAS G12C selective inhibitor in patients with solid tumors.Contract Pharma Staff 09.17.20
-
Breaking News | Promotions & Moves
Boyds Bolsters Clinical Ops Team
Appoints senior clinical research associate.Contract Pharma Staff 09.17.20
-
-
Capsules | Solid Dosage/Creams/Ointments
Beyond the Boundaries
New capsule types resolve emerging formulation needs.Sven Stegemann, ACG Capsules 09.09.20
-
September 2020: Auction of Equipment from a Leading Global Biopharmaceutical Company
By Justin Kadis
-
Breaking News | Clinical Trials | Industry News | Information Technology | Logistics | Packaging & Tracking | Supply Chain
Sharp Bolsters Clinical Trials Services Capabilities
Launches Clinventory Inventory Management System (IMS) for clinical trials.09.08.20
-
Clinical Trials | CRO News | Drug Development
PPD, Lupus Therapeutics to Support Lupus Clinical Research
To provide enhanced protocol and trial optimization capabilities for its customers leveraging LT’s scientific, operational and drug development expertise.Contract Pharma Staff 09.04.20
-
Breaking News | Clinical Trials
GI Partners Acquires Clinical Ink
Plans to accelerate Clinical Ink’s innovation in clinical trial workflow solutions.Contract Pharma Staff 08.27.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances
Sutro Biopharma Achieves Merck KGaA Clinical Supply Milestone
Delivers GMP clinical trial supply to Merck KGaA for Phase 1 trial of M1231, a bispecific ADC for the treatment of solid tumors.Contract Pharma Staff 08.25.20
-
Clinical Trials | Drug Development
Beyond 2020: The Future of CROs
How will remote site access impact the CRO business?Ryan Jones, CEO, Florence Healthcare 08.21.20
-
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
JanOne Readies for Clinical GMP Manufacturing Run
JAN101 formulation ready for Phase 2b peripheral artery disease trials and for potential treatment of COVID-19 vascular inflammation.Contract Pharma Staff 08.20.20
-
-
-
-
-
-
Importing Clinical Supplies into China
Water Cooler Chat
-
-
-
-
Breaking News | Facilities
Heritage Global and Federal Equipment Company to Conduct Auction of Manufacturing Site
Online auction features processing and lab equipment.Contract Pharma Staff 07.31.20
-
PCI Pharma Services Announces Global Expansion of Clinical Trial Services
PCI Broadens Global Clinical Supply-Chain Service Offerings Into Mainland Europe
-
Breaking News | Clinical Trial Materials | Cold Chain Management | Industry News
PCI Pharma Services Expands with New Clinical COE in Berlin
17,000 sq.-ft. flagship site dedicated to primary and secondary packaging, storage at all temperature ranges, and distribution.Contract Pharma Staff 07.28.20
-
-
Importing Clinical Supplies into Japan
Water Cooler Chat
-
Bio News | Breaking News | Clinical Trial Materials | Facilities | Industry News
Catalent Expands Clinical Manufacturing Operations
Invests $30 million to create European clinical manufacturing center of excellence in Limoges, France.Contract Pharma Staff 07.21.20
-
Modified Release Dosage Forms: Giving New Life to Drugs
Considerations for developing modified release versions of an immediate release product.Contract Pharma Staff
-
Breaking News | Clinical Trials
University of Oxford Selects Axiom eClinical Suite for Clinical Trial
Will focus on COVID-19 preventative treatments.Contract Pharma Staff 07.07.20
-
Breaking News | Industry News
iBio Receives IBM Clinical Development Solution
Designed to support clinical COVID-19 vaccine candidates.Contract Pharma Staff 06.30.20
-
Breaking News | Drug Development | Industry News
Oncology Venture Out-Licenses Clinical Assets to Smerud
Smerud will advance development of LiPlaCis in late stage metastatic breast cancer and 2X-111 in glioblastoma multiforme.Contract Pharma Staff 06.29.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution
Offers integrated data collection, actionable views of critical study data, COVID-19 targeted risk management and recovery assessment.Contract Pharma Staff 06.29.20
-
Drug Delivery
Not Your Father’s Oral Thin Film
A look at how oral film drug delivery is evolving.Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20
-
APIs | cGMP Manufacture | Clinical Trials | Supply Chain
Evaluating Pharma Amid COVID-19
Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformationKristin Brooks, Contract Pharma 05.18.20
-
Clinical Trials
Pioneering Medicine Forward
May 20th marks Clinical Trials Day, celebrating 273 years of clinical trialsTina Bland, Senior Consultant, KCR Trial Execution Consulting 05.18.20
-
cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
WuXi Launches CAR-T Cell Therapy Platform
Will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene therapies for patientsContract Pharma Staff 05.18.20
-
Breaking News | Collaborations & Alliances | Industry News
Duke, GenScript, A*STAR Enter COVID-19 Pact
Launch SARS-CoV-2 serology test to detect neutralizing antibodies without need of containment facility or specimenContract Pharma Staff 05.18.20
-
Breaking News | Facilities | Industry News | Inspections
PharmaCyte Conducts Final Audit of Mfg. Facility
Batch records in Thailand have been deemed cGMP compliantContract Pharma Staff 05.18.20
-
Breaking News | Drug Development | Industry News
VSY Biotech Develops TR-C 19 Candidate to Treat COVID-19
Studies have shown that TR-C 19 can neutralize the virus isolated under lab conditions, clinical trials are underway.Contract Pharma Staff 05.15.20
-
Industry News
FDA COVID-19 Update
To date, the FDA has authorized 98 tests under EUAs, which include 85 molecular tests, 12 antibody tests, and 1 antigen test.Contract Pharma Staff 05.15.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Exyte and Univercells Join Forces
Partner for rapid deployment of vaccine production plants in the wake of the COVID-19 crisisContract Pharma Staff 05.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CMAB Completes Devt. and Mfg. Project for QureBio
Bispecific antibody Q-1802 will enter clinical trials to assess treatment of solid tumors such as gastric cancerContract Pharma Staff 05.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Vibalogics to Manufacture Clinical Material for Janssen
CDMO to provide additional clinical trial material for COVID-19 vaccine candidateContract Pharma Staff 05.14.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Sabin and ReiThera Enter Clinical Manufacturing Pact
BARDA provides the Sabin Vaccine Institute with additional $20mn for further development of Ebola Sudan and Marburg vaccinesContract Pharma Staff 05.14.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
FairJourney Biologics Joins Forces with Iontas
Create a global platform for outsourced antibody discovery services.Contract Pharma Staff 05.13.20
-
Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Catalent, Ennaid Therapeutics Ink COVID-19 Program Pact
Catalent will develop a powder-in-capsule formulation of Ennaid’s ENU200 program, a repurposed antiviral drug for the potential treatment of COVID-19Contract Pharma Staff 05.13.20
-
Bioassay Development
QPS Announces COVID-19 Testing Capability
Developed a QPCR assay to identify active novel coronavirus infections.Contract Pharma Staff 05.13.20
-
APIs | Breaking News | cGMP Manufacture | Excipients | Industry News
Evonik Commissions Advanced Biomaterials Production Facility
Expands range of CMO services for the scale-up and commercial manufacturing of customer’s own excipients in Birmingham, AL.Contract Pharma Staff 05.13.20
-
Breaking News | Clinical Trial Materials | Industry News | Logistics | Supply Chain
Marken Expands Direct To Patient Services
India allows home delivery of clinical trial medications during COVID-19 pandemic lock down.Contract Pharma Staff 05.13.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Singota Solutions Collaborates with Noveome Biotherapeutics
To manufacture therapy to treat severe condition in people infected with COVID-19Contract Pharma Staff 05.12.20
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Supply Chain
Yourway and Firma Ink Clinical Supply Deal
Collaborate to administer coordinated supply delivery for home-health clinical trial visitsContract Pharma Staff 05.12.20
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Key Biologics and Astarte Biologics Rebrand
Will now be known as CelleroContract Pharma Staff 05.12.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Sarepta and Dyno Therapeutics Will Develop Next-Gen Gene Therapy Vectors
Dyno’s proprietary CapsidMap platform opens up new ways to identify novel capsidsContract Pharma Staff 05.12.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
HJB, Mabspace Ink Development and Manufacturing Agreement
Program aims to bring more efficacious treatment options to cancer patientsContract Pharma Staff 05.12.20
-
Breaking News | Clinical Trials | Industry News
Tufts CSDD Releases New Study
Establishes demographic benchmarks for pivotal clinical trials, showing areas of under-representationContract Pharma Staff 05.12.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Themis Collaborates with ABL Europe
ABL will manufacture Themis’ SARS-CoV-2 vaccine candidate in FranceContract Pharma Staff 05.12.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Junshi, Lilly to Develop Antibody Therapies for COVID-19
Multiple neutralizing antibodies have been engineered, with the lead asset poised to enter clinical testing in the second quarterContract Pharma Staff 05.12.20
-
Capsules | Fill/Finish | Solid Dosage/Semi-solids
Syntegon Hosts Virtual Show: New Technologies for Solid Dosage Forms
Launches Sepion Coater series in six sizes, continuous production from powder to capsule, and APD tool that determines optimum process parameters for capsules.05.11.20
-
-
Breaking News | cGMP Manufacture | Industry News
HCATS, Apceth Expand Manufacturing Pact with Bluebird Bio
Enter long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.Contract Pharma Staff 05.11.20
-
Collaborations & Alliances | Drug Development | Drug Discovery
Regeneron, CCPM Enter Genetics Research Alliance
Large-scale genomics initiative aims to advance human genetics and precision medicineContract Pharma Staff 05.11.20
-
Breaking News | Industry News
FDA COVID-19 Update
Authorizes the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testingContract Pharma Staff 05.11.20
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Catalent Provides Clinical Support for COVID-19 Study
Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patientsContract Pharma Staff 05.08.20
-
Bio News | Breaking News | Clinical Trials | Industry News
Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution
Designed to evaluate clinical trial protocol and charter to determine if novel COVID endpoint adjudication pathways should be addedContract Pharma Staff 05.08.20
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Reader Showcase
MilliporeSigma Launches Bio4C Software Suite
Bio4C digital ecosystem combines process control, analytics and plant-level automationContract Pharma Staff 05.07.20
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Romark Initiates Trials of NT-300 for COVID-19 Prevention
In cell cultures, the active ingredient in NT-300, nitazoxanide, inhibits replication of a broad range of respiratory viruses, including SARS-CoV-2.Contract Pharma Staff 04.27.20
-
Breaking News | Industry News
FDA COVID-19 Update
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquineContract Pharma Staff 04.27.20
-
Breaking News | Drug Development | Industry News
Valo Tx Working to Develop Potential COVID-19 Vaccine
Will use PeptiCRAd technology with HLA-matched peptides optimized to further boost CD8+ T-cell immune responses.Contract Pharma Staff 04.27.20
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
CRO Industry Update
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.Kristin Brooks, Contract Pharma 04.27.20
-
Breaking News | Drug Development | Industry News
Santhera, CSHL to Investigate Lonodelestat in COVID-19-related ARDS
Lonodelestat (POL6014), a potent inhibitor of human neutrophil elastase (hNE), has potential as a therapeutic intervention for COVID-19-related ARDS.Contract Pharma Staff 04.27.20
-
Breaking News | Drug Development | Industry News
AGC Biologics, AdaptVac Partner to Develop COVID-19 Vaccine
Will leverage AdaptVac's Virus-Like Particle (VLP) technology that could provide a solution to protect against new SARS-CoV-2 infections.Contract Pharma Staff 04.27.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Regeneron, Sanofi Release Preliminary Phase II Kevzara Results in COVID-19
Kevzara rapidly lowered C-reactive protein (CRP), a key marker of inflammation, meeting the primary endpoint.Contract Pharma Staff 04.27.20
-
Vetter’s high performance is again recognized at the 2020 CMO Leadership Awards
A win in all six core categories reaffirms Vetter as a trusted solution provider
-
New iPSC Master Cell Banks to Accelerate Development of Novel Cell Therapies
panCELLa and CCRM collaborate to benefit academia and industry
-
-
Clinical Trials | Information Technology | QA/QC
Managing Clinical Trials Amid the Coronavirus Pandemic
Patrick Hughes of CluePoints discusses the impact on clinical trials and how leveraging data may herald a long overdue paradigm shift in the industry.Kristin Brooks, Contract Pharma 04.06.20
-
Clinical Trials | CRO News | Drug Development | Industry News | Information Technology
Janssen, PRA Design First Mobile Virtual Trial
Kent Thoelke and Greg Licholai of PRA discuss the alliance, advances that have made virtual clinical trials possible, and the obstacles that remainKristin Brooks, Contract Pharma 01.06.20
-
Breaking News | Drug Delivery | Drug Development | Industry News
Recipharm Invests in Inhalation Development Services
Installs SprayVIEW system to support inhalation and nasal product development at RTP, NC facility12.09.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Navrogen, Lonza Enter Bio Production Deal
Sign agreement to use Lonza’s GS Gene Expression System for Navrogen’s anti-HIO targeting agents.11.22.19
- Industry News | Packaging & Tracking